Your browser doesn't support javascript.
Quantifying previous SARS-CoV-2 infection through mixture modelling of antibody levels.
Bottomley, C; Otiende, M; Uyoga, S; Gallagher, K; Kagucia, E W; Etyang, A O; Mugo, D; Gitonga, J; Karanja, H; Nyagwange, J; Adetifa, I M O; Agweyu, A; Nokes, D J; Warimwe, G M; Scott, J A G.
  • Bottomley C; International Statistics and Epidemiology Group, London School of Hygiene & Tropical Medicine, London, UK. christian.bottomley@lshtm.ac.uk.
  • Otiende M; Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK. christian.bottomley@lshtm.ac.uk.
  • Uyoga S; Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.
  • Gallagher K; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.
  • Kagucia EW; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.
  • Etyang AO; Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.
  • Mugo D; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.
  • Gitonga J; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.
  • Karanja H; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.
  • Nyagwange J; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.
  • Adetifa IMO; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.
  • Agweyu A; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.
  • Nokes DJ; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.
  • Warimwe GM; Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.
  • Scott JAG; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.
Nat Commun ; 12(1): 6196, 2021 10 26.
Article in English | MEDLINE | ID: covidwho-1493097
ABSTRACT
As countries decide on vaccination strategies and how to ease movement restrictions, estimating the proportion of the population previously infected with SARS-CoV-2 is important for predicting the future burden of COVID-19. This proportion is usually estimated from serosurvey data in two

steps:

first the proportion above a threshold antibody level is calculated, then the crude estimate is adjusted using external estimates of sensitivity and specificity. A drawback of this approach is that the PCR-confirmed cases used to estimate the sensitivity of the threshold may not be representative of cases in the wider population-e.g., they may be more recently infected and more severely symptomatic. Mixture modelling offers an alternative approach that does not require external data from PCR-confirmed cases. Here we illustrate the bias in the standard threshold-based approach by comparing both approaches using data from several Kenyan serosurveys. We show that the mixture model analysis produces estimates of previous infection that are often substantially higher than the standard threshold analysis.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 / Antibodies, Viral Type of study: Diagnostic study / Observational study / Prognostic study / Systematic review/Meta Analysis Topics: Vaccines Limits: Humans Country/Region as subject: Africa Language: English Journal: Nat Commun Journal subject: Biology / Science Year: 2021 Document Type: Article Affiliation country: S41467-021-26452-z

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 / Antibodies, Viral Type of study: Diagnostic study / Observational study / Prognostic study / Systematic review/Meta Analysis Topics: Vaccines Limits: Humans Country/Region as subject: Africa Language: English Journal: Nat Commun Journal subject: Biology / Science Year: 2021 Document Type: Article Affiliation country: S41467-021-26452-z